ADMA Biologics Inc Common Stock (NASDAQ: ADMA) last traded at $9.84, up 0.82% on the session. The quote above updates while this page is open; the figures below are drawn from ADMA Biologics Inc Common Stock’s own filings and are restated only when a new one is published.
ADMA Biologics Inc Common Stock trades on NASDAQ under the ticker ADMA. Its market capitalisation is $2.20 billion.
Valuation measures for ADMA Biologics Inc Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.20B |
|---|---|
| Enterprise value | $2.34B |
| P/E ratio | 14.06 |
| Price / sales | 4.30 |
| Price / book | 5.40 |
| Beta | 0.81 |
Trailing-twelve-month figures tagged in ADMA Biologics Inc Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $512.27M |
|---|---|
| Net income (TTM) | $168.96M |
| EPS (TTM) | $0.700 |
| Gross margin | 64.71% |
| Operating margin | 43.82% |
| Return on equity | 41.39% |
| Cash | $136.02M |
Range and volume for ADMA over the past 52 weeks.
| 52-week high | $20.46 |
|---|---|
| 52-week low | $7.21 |
| Volume | 1.41M |
| Average volume | 3.00M |
| Previous close | $9.76 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.